Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis

British Journal of General Practice

Volumn 46, Issue 402, 1996, Pages 15-18

  Tirimanna, P R S ^a   Den Otter, J J ^a   Van Schayck, C P ^a   Van Herwaarden, C L A ^a   Folgering, H ^a   Van Weel, C ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Airways obstruction; Asthma; Lung function; Peak expiratory flow recordings

Indexed keywords

BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; SALBUTAMOL; STEROID;

ADULT; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; FEMALE; FORCED EXPIRATORY VOLUME; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NETHERLANDS; PEAK EXPIRATORY FLOW; PROGNOSIS; SPIROMETER;

ADULT; AGED; ASTHMA; BRONCHITIS; CHRONIC DISEASE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE;

EID: 9044229140     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. United States Department of Health and Human Services. International consensus report on diagnosis and treatment of asthma. Eur Respir J 1992; 5: 601-641.
2. British Thoracic Society. Guidelines on the management of asthma. Thorax 1993; 48 suppl: s1-s24.
3. Lebowitz MJ. The use of peak expiratory flow measurements in respiratory diseases. Pediatr Pulmonol 1991; 11: 166-174.
4. Dekker FW, Schrier AC, Sterk PJ, Dijkman JH. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax 1992; 47: 162-166.
5. Burrows B, Bloom JW, Traver GA, Cline MG. The course and prognosis of different forms of chronic airways obstruction in a sample of the general population. N Engl J Med 1987; 317: 1309-1314.
6. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
7. 1. Chest 1983; 83: 717-724.
8. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70: 171-179.
9. Dompeling E, van Schayck CP, van Grunsven PM, et al Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. Ann Intern Med 1993; 118: 770-778.
10. 1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax 1988; 43: 335-336.
11. van Schayck CP, Dompeling E, van Herwaarden CLA, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ 1991; 303: 1426-1431.
12. Dompeling E, van Schayck CP, Folgering H, et al Accuracy, precision and linearity of the portable flow volume meter Microspiro HI-298. Eur Respir J 1991; 4: 612-615.
13. Boman G, Backer U, Larsson S, et al. Oral acerylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organised by the Swedish society for pulmonary diseases. Eur J Respir Dis 1983; 64: 405-415.
14. van Schayck CP, Dompeling E, van Weel C, et al Accuracy and reproducibility of the Assess peak flow meter. Eur Respir J 1990; 3: 338-341.
15. Clark TJH, Godfrey S, Lee TH. Asthma. 3rd edition. London: Chapman and Hall Medical, 1992.